Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    MYLAN
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
MYLAN
Dec-18
JUBILANT PHARMOVA /
MYLAN
5-Yr Chart
Click to enlarge
High Rs4963,969-   
Low Rs2692,185-   
Sales per share (Unadj.) Rs394.41,826.3-  
Earnings per share (Unadj.) Rs-4.149.6-  
Cash flow per share (Unadj.) Rs30.7391.5-  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs338.61,975.7-  
Shares outstanding (eoy) m159.28514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.01.7 57.5%   
Avg P/E ratio x-93.862.0 -151.2%  
P/CF ratio (eoy) x12.47.9 158.4%  
Price / Book Value ratio x1.11.6 72.5%  
Dividend payout %-122.70-   
Avg Mkt Cap Rs m60,8731,582,973 3.8%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m21,6600-   
Avg. sales/employee Rs Th026,846.0-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0729.0-  
INCOME DATA
Net Sales Rs m62,817939,609 6.7%  
Other income Rs m3830-   
Total revenues Rs m63,201939,609 6.7%   
Gross profit Rs m7,317243,136 3.0%  
Depreciation Rs m5,540175,932 3.1%   
Interest Rs m1,88245,192 4.2%   
Profit before tax Rs m27822,012 1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m927-3,502 -26.5%   
Profit after tax Rs m-64925,514 -2.5%  
Gross profit margin %11.625.9 45.0%  
Effective tax rate %333.5-15.9 -2,096.6%   
Net profit margin %-1.02.7 -38.0%  
BALANCE SHEET DATA
Current assets Rs m37,624524,677 7.2%   
Current liabilities Rs m17,724382,547 4.6%   
Net working cap to sales %31.715.1 209.4%  
Current ratio x2.11.4 154.8%  
Inventory Days Days2584 29.3%  
Debtors Days Days5693 59.9%  
Net fixed assets Rs m71,668182,269 39.3%   
Share capital Rs m159500 31.8%   
"Free" reserves Rs m53,7720-   
Net worth Rs m53,9311,016,486 5.3%   
Long term debt Rs m31,1041,097,114 2.8%   
Total assets Rs m109,2922,726,609 4.0%  
Interest coverage x1.11.5 77.2%   
Debt to equity ratio x0.61.1 53.4%  
Sales to assets ratio x0.60.3 166.8%   
Return on assets %1.12.6 43.5%  
Return on equity %-1.22.5 -47.9%  
Return on capital %2.53.2 79.9%  
Exports to sales %00-   
Imports to sales %4.10-   
Net fx Rs m4,5360-   
CASH FLOW
From Operations Rs m6,607195,251 3.4%  
From Investments Rs m-5,444-100,923 5.4%  
From Financial Activity Rs m-1,567-90,959 1.7%  
Net Cashflow Rs m3011,618 18.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.38 Rs / USD

Compare JUBILANT PHARMOVA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare JUBILANT PHARMOVA With: BIOFIL CHEMICALS  VENUS REMEDIES  SHELTER PHARMA  ALKEM LABORATORIES  CORAL LAB.  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.